semaglutide baylor scott and white & Family Medical Center – North Garland Baylor Scott & White Health

The abdomen typically has more subcutaneous fat and is the most common injection site, where 4 mm needles are generally sufficient

Known Risks of GLP-1 Use While Nursing The primary concern with GLP-1 therapy in breastfeeding mothers is not confirmed harm to infants but rather the lack of specific safety data in this population

The active ingredient in medications such as Ozempic (FDA-approved for Type 2 diabetes and cardiovascular risk reduction) and Wegovy (FDA-approved for weight loss and long-term weight management), semaglutide works by mimicking the action of a natural hormone called glucagon-like peptide-1

This combined approach may provide meaningful benefits, especially for those managing both weight and blood pressure challenges